New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr Matthew Smith, West Midlands Regional Genetics Service, Birmingham, UK and Alice Tuff-Lacey, Cancer Research UK, London, talk to ecancer at the 2013 WIN Symposium about next generation sequencing and biobanks.
Over the past two years and across three technical hubs, 9,000 patients have had samples of their blood and tissue sent for testing for a small range of genes, then analyzed and stored for future reference.
All of the DNA samples are stored in a central repository, accessible through Cancer Research UK. This biobank collaboration began with CRUK looking at stratified medicine and its delivery within the NHS.
Filmed in Partnership with the WIN Consortium
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
The genomics of cancer in Africa
DNA methylation profile of prostate cancer aggressiveness in Ghana
Lung Cancer
OncoAlert Round Up for August 25th - 31st, 2023
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death